Curis, Inc. (CRIS) was a big mover last session as its shares surged around 12% on the day. The surge came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the healthcare company as the stock is now down over 27% in the past one-month time frame.
In the last 30-day frame, Curis witnessed five negative estimate revisions and the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Curis currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
However, some better-ranked biotechnology stocks include Actelion Ltd. (ALIOF), InSiteVision Inc. (INSV) and Heska Corp. (HSKA). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment